[
  {
    "ts": "2025-12-05T02:26:01+00:00",
    "headline": "Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on Notes From The Beauty Contest’s Substack by Crashkolnikov. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc.’s share was trading at $750.11 as of December 1st. REGN’s trailing and forward P/E were 18.70 and 18.52 respectively according to Yahoo Finance. Regeneron Pharmaceuticals (REGN) […]",
    "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-inc-regn-bull-022601844.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "1024464b-2798-3051-a635-617ed805b7e4",
      "content": {
        "id": "1024464b-2798-3051-a635-617ed805b7e4",
        "contentType": "STORY",
        "title": "Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on Notes From The Beauty Contest’s Substack by Crashkolnikov. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc.’s share was trading at $750.11 as of December 1st. REGN’s trailing and forward P/E were 18.70 and 18.52 respectively according to Yahoo Finance. Regeneron Pharmaceuticals (REGN) […]",
        "pubDate": "2025-12-05T02:26:01Z",
        "displayTime": "2025-12-05T02:26:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/6519ef2f4e4b231550d54aa969252071",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "10 Pharmacist Shortage Countries in Need of Pharmacists in 2017",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7rkz3rC00SNtixCrKzs9yw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/6519ef2f4e4b231550d54aa969252071.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/psURJKZpk6G_2cjLQz2IOw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/6519ef2f4e4b231550d54aa969252071.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-inc-regn-bull-022601844.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-inc-regn-bull-022601844.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]